Among these, semaglutide has demonstrated reduced risk of major adverse cardiovascular events (MACE) in trial participants with moderate or high cardiovascular risk
Fukami A, Seino Y, Ozaki N et al (2013) Ectopic expression of GIP in pancreatic -cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Although L-arginine is considered safe in moderate doses, too much L-arginine can have severe side effects, including death
Hospitalogy Top Reads & Resources My favorite healthcare essays from the week Health Tech Bytes piece on heart scans was a fun Valentines day read into practical uses of AI and how AI enables new possibilities within radiology
Vaccine Delivery Phases [Internet]